Anika Therapeutics reported $8.35M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US USD 39.71M 1.29M
Agios Pharmaceuticals AGIO:US USD 10.42M 2.62M
Anika Therapeutics ANIK:US USD 8.35M 188K
Arrowhead Research ARWR:US USD 2.87M 3.03M
Clovis Oncology CLVS:US USD 18.12M 6.1M
Enanta Pharmaceuticals ENTA:US USD 6M 4.76M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Heron Therapeutics HRTX:US USD 6.55M 7.26M
Immunogen IMGN:US USD 20.18M 2.93M
Insmed INSM:US USD 11.58M 19.57M
Integra Lifesciences IART:US USD 80.73M 11.23M
Intrexon XON:US USD 4.2M 1.53M
Karyopharm Therapeutics KPTI:US USD 813K 881K
Macrogenics MGNX:US USD 4.62M 2.01M
Merit Medical Systems MMSI:US USD 63.21M 3.76M
Peregrine Pharmaceuticals PPHM:US USD 23.33M 7.13M
Rigel Pharmaceuticals RIGL:US USD 2.72M 566K
Sangamo Biosciences SGMO:US USD 17.38M 4.3M
Smith & Nephew PLC SN/:LN 1.01B 83M
Veracyte VCYT:US USD 11.11M 786K
Xencor XNCR:US USD 14.62M 1.13M